Swiss Life Asset Management Ltd Grows Stock Position in Stryker Corporation $SYK

Swiss Life Asset Management Ltd boosted its holdings in Stryker Corporation (NYSE:SYK) by 6.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 40,438 shares of the medical technology company’s stock after acquiring an additional 2,454 shares during the period. Swiss Life Asset Management Ltd’s holdings in Stryker were worth $14,213,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SYK. Brighton Jones LLC grew its position in shares of Stryker by 15.4% in the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock valued at $1,643,000 after purchasing an additional 609 shares during the last quarter. Schnieders Capital Management LLC. acquired a new position in shares of Stryker during the 2nd quarter worth approximately $205,000. Marshall Wace LLP lifted its stake in Stryker by 107.9% in the 2nd quarter. Marshall Wace LLP now owns 5,700 shares of the medical technology company’s stock valued at $2,255,000 after buying an additional 77,831 shares in the last quarter. Nebula Research & Development LLC purchased a new stake in Stryker in the 2nd quarter valued at approximately $219,000. Finally, HUB Investment Partners LLC acquired a new stake in Stryker during the 2nd quarter valued at $253,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft set a $315.00 price target on Stryker in a report on Friday, May 1st. Canaccord Genuity Group decreased their price objective on Stryker from $435.00 to $400.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Wells Fargo & Company dropped their price objective on Stryker from $456.00 to $418.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Evercore set a $355.00 target price on shares of Stryker in a report on Friday, May 1st. Finally, TD Cowen cut shares of Stryker from a “buy” rating to a “hold” rating and set a $387.00 price target on the stock. in a research note on Monday, January 26th. Sixteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $395.48.

Stryker Stock Down 0.9%

SYK opened at $282.85 on Tuesday. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. The stock has a market capitalization of $108.33 billion, a price-to-earnings ratio of 32.74, a price-to-earnings-growth ratio of 1.80 and a beta of 0.80. The business has a 50-day moving average of $336.33 and a two-hundred day moving average of $353.81. Stryker Corporation has a 12 month low of $281.00 and a 12 month high of $404.87.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The company had revenue of $6.02 billion for the quarter, compared to analysts’ expectations of $6.34 billion. During the same quarter in the previous year, the company earned $2.84 earnings per share. The company’s revenue was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, research analysts expect that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio (DPR) is 40.74%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.